Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Andersen

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Transfusion|January 1, 1996
Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storageI Federowicz, B B Barrett, J W Andersen, et al.
Cancer Research|December 15, 1995
c-fos is not essential for v-abl-induced lymphomagenesisE Saez, H Oppenheim, J Smoluk, et al.
Blood|July 1, 1990
Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemiaR Dadmarz, S N Rabinowe, S A Cannistra, et al.
Cancer|October 1, 1989
Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group StudyR T Skeel, J W Andersen, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemiaE H Rubin, J W Andersen, D T Berg, et al.
Leukemia|November 1, 1992
Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experienceJ M Rowe, J W Andersen, P A Cassileth, et al.
Leukemia & Lymphoma|July 1, 1995
Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphomaJ J Mazza, J D Hines, J W Andersen, et al.
British Journal of Haematology|December 1, 1992
The production of steel factor mRNA in Diamond-Blackfan anaemia long-term cultures and interactions of steel factor with erythropoietin and interleukin-3C A Sieff, C T Yokoyama, K M Zsebo, et al.
Transfusion|January 1, 1995
Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood componentsJ S Dzieczkowski, B B Barrett, D Nester, et al.
The New England Journal of Medicine|November 5, 1992
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphomaR V Smalley, J W Andersen, M J Hawkins, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Transfusion|January 1, 1996
Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storageI Federowicz, B B Barrett, J W Andersen, et al.
Cancer Research|December 15, 1995
c-fos is not essential for v-abl-induced lymphomagenesisE Saez, H Oppenheim, J Smoluk, et al.
Blood|July 1, 1990
Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemiaR Dadmarz, S N Rabinowe, S A Cannistra, et al.
Cancer|October 1, 1989
Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group StudyR T Skeel, J W Andersen, D C Tormey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemiaE H Rubin, J W Andersen, D T Berg, et al.
Leukemia|November 1, 1992
Post-remission therapy in adults with acute myelogenous leukemia: the Eastern Cooperative Oncology Group (ECOG) experienceJ M Rowe, J W Andersen, P A Cassileth, et al.
Leukemia & Lymphoma|July 1, 1995
Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphomaJ J Mazza, J D Hines, J W Andersen, et al.
British Journal of Haematology|December 1, 1992
The production of steel factor mRNA in Diamond-Blackfan anaemia long-term cultures and interactions of steel factor with erythropoietin and interleukin-3C A Sieff, C T Yokoyama, K M Zsebo, et al.
Transfusion|January 1, 1995
Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood componentsJ S Dzieczkowski, B B Barrett, D Nester, et al.
The New England Journal of Medicine|November 5, 1992
Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphomaR V Smalley, J W Andersen, M J Hawkins, et al.
Pageof 6